[Medium-weight molecules in the blood serum of patients with hyperplastic processes in the endometrium and benign and malignant ovarian tumors].
Measurements of blood serum medium mass molecule (MMM) levels in patients with benign and stages III-IV malignant tumors of the ovaries have shown that MMM levels are significantly elevated in the patients with the hyperplastic processes in the endometrium, malignant and benign ovarian tumors. In health MMM level is 0.238 U, in patients with the endometrial hyperplasia and benign ovarian tumors it has been found to make up 0.358 U, in Stage III malignant epithelial tumors this value has been 0.439 U, and in Stage IV tumors 0.366 U. After therapy, resulting in a prolonged remission, MMM level reduced to 270 U on an average. Therefore MMM measurements in the blood serum may be recommended as a test for monitoring the course of a malignant process and the treatment results.